Bioengineering an effective, small diameter (< 6 mm) artificial vascular graft for use in
bypass surgery when autologous grafts are unavailable remains a persistent challenge …

Cardiovascular disease serves as the leading cause of death worldwide, with stenosis,
occlusion, or severe dysfunction of blood vessels being its pathophysiological mechanism …

Current approaches in small-diameter vascular grafts for coronary artery bypass surgeries
fail to address physiological variations along the graft that contribute to thrombus formation …

Vascular grafts are widely used for vascular surgeries, to bypass a diseased artery or
function as a vascular access for hemodialysis. Bioengineered or tissue-engineered …

Small-diameter vascular grafts (SDVGs) cannot meet current clinical demands owing to their
suboptimal long-term patency rate. Various materials have been employed to address this …

Inhibiting thrombus formation and intimal hyperplasia is essential for orthotopic tissue-
engineered vascular grafts. The matching mechanical properties of autologous blood …

Tissue-engineered vascular grafts (TEVGs) made of human textiles have been recently
introduced and offer remarkable biocompatibility as well as tunable mechanical properties …

In vitro assessment of small‐diameter synthetic vascular grafts usually uses standard cell
culture conditions with early‐passage cells. However, these conduits are mainly implanted …

Biomedical implants possessing the structural and functional characteristics of extracellular
matrix (ECM) are pivotal for vascular applications. This study investigated the potential of …

Tissue engineering has driven significant research in the strive to create a supply of tissues
for patient treatment. Cell integration into engineered tissues maximizes functional …